Stay updated on Immunostrategies in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunostrategies in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trial page.

Latest updates to the Immunostrategies in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check17 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference0.8%

- Check24 days agoChange DetectedThe footer’s ClinicalTrials.gov software revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check31 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check52 days agoChange DetectedThe record history now includes a new revision tag v3.7.0 and removes the previous v3.6.6 entry, indicating an update to the history log rather than a change to the study details.SummaryDifference0.1%

- Check73 days agoChange DetectedThe record history now shows a new revision entry for v3.6.6, with the previous v3.6.5 removed, indicating an update to the page's versioning.SummaryDifference0.1%

Stay in the know with updates to Immunostrategies in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunostrategies in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trial page.